COVID-19: Difficult trade-offs in AstraZeneca vaccine development

general news
The Oxford vaccine ChAdOx1 is seen as a promising candidate to combat COVID-19. But critics believe that research is going too fast and that risks could be being played down. What is true about the accusations?


Read full article on dw general